Avantor (AVTR) Cash from Investing Activities (2018 - 2025)
Avantor (AVTR) posted quarterly Cash from Investing Activities of -$39.7 million for Q4 2025, down 107.11% year-over-year from $558.5 million in Q4 2024, and down 19.22% quarter-over-quarter from -$33.3 million in Q3 2025.
Avantor (AVTR) Cash from Investing Activities (2018 - 2025) Analysis & Trends
Avantor's Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$39.7 million for Q4 2025.
- In Q4 2025, Cash from Investing Activities fell 107.11% year-over-year to -$39.7 million; the TTM figure through Dec 2025 stood at -$130.5 million (down 129.84% YoY), while the FY2025 annual figure was -$130.5 million, down 129.73% from the prior year.
- Cash from Investing Activities for Q4 2025 stood at -$39.7 million, down from -$33.3 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $558.5 million in Q4 2024, with the low at -$50.0 million in Q4 2023.
- The 4-year median for Cash from Investing Activities is -$33.2 million (2022), against an average of $10.0 million.
- The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities plunged 1002.44% in 2023, then soared 1217.0% in 2024.
- Avantor's Cash from Investing Activities stood at -$33.1 million in 2022, then sank by 51.06% to -$50.0 million in 2023, then jumped by 1217.0% to $558.5 million in 2024, then tumbled by 107.11% to -$39.7 million in 2025.
- Business Quant data shows AVTR's Cash from Investing Activities at -$39.7 million in Q4 2025, -$33.3 million in Q3 2025, and -$28.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | Avantor | 9.76 Bn | 9.45 Bn | 537.00 Mn | -37.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -39.70 Mn |
| Dec 31, 2025 | -39.70 Mn |
| Sep 30, 2025 | -33.30 Mn |
| Sep 30, 2025 | -33.30 Mn |
| Jun 30, 2025 | -28.60 Mn |
| Jun 30, 2025 | -28.60 Mn |
| Mar 31, 2025 | -28.90 Mn |
| Mar 31, 2025 | -28.90 Mn |
| Dec 31, 2024 | 558.50 Mn |
| Dec 31, 2024 | 558.50 Mn |
| Mar 31, 2024 | -34.20 Mn |
| Mar 31, 2024 | -34.20 Mn |
| Dec 31, 2023 | -50.00 Mn |
| Dec 31, 2023 | -50.00 Mn |
| Sep 30, 2023 | -37.00 Mn |
| Sep 30, 2023 | -37.00 Mn |
| Jun 30, 2023 | -29.40 Mn |
| Jun 30, 2023 | -29.40 Mn |
| Mar 31, 2023 | -27.30 Mn |
| Mar 31, 2023 | -27.30 Mn |